The C-terminal 26-residue peptide of serpin A1 is an inhibitor of HIV-1

Biochemical and Biophysical Research Communications

Volumn 343, Issue 2, 2006, Pages 617-622

  Congote, Luis Fernando ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

1 Antitrypsin; Antithrombin III; CD36; CD91; Interferon 2; LDL receptor related protein; Proteinase inhibitor 9; U937 cells

Indexed keywords

PEPTIDE; PHYTOHEMAGGLUTININ; SERINE PROTEINASE INHIBITOR; SERPIN A1; STAT1 PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; PERIPHERAL BLOOD MONONUCLEAR CELL; PHOSPHORYLATION; PRIORITY JOURNAL; VIRUS EXPRESSION;

ALPHA 1-ANTITRYPSIN; ANTIVIRAL AGENTS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; PEPTIDE FRAGMENTS; PEPTIDES; U937 CELLS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33645114215     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.02.190     Document Type: Article

References (31)

1. J.A. Huntington, R.J. Read, and R.W. Carrell Structure of a serpin-protease complex shows inhibition by deformation Nature 407 2000 923 926
2. G. Joslin, R.J. Fallon, J. Bullock, S.P. Adams, and D.H. Perlmutter The SEC receptor recognizes a pentapeptide neodomain of alpha 1-antitrypsin-protease complexes J. Biol. Chem. 266 1991 11282 11288
3. M.Z. Kounnas, F.C. Church, W.S. Argraves, and D.K. Strickland Cellular internalization and degradation of antithrombin III-thrombin, heparin cofactor II-thrombin, and alpha 1-antitrypsin-trypsin complexes is mediated by the low density lipoprotein receptor-related protein J. Biol. Chem. 271 1996 6523
4. S. Janciauskiene, H.T. Wright, and S. Lindgren Atherogenic properties of human monocytes induced by the carboxyl terminal proteolytic fragment of alpha-1-antitrypsin Atherosclerosis 147 1999 263 275
5. A. Nykjaer, and T.E. Willnow The low-density lipoprotein receptor gene family: a cellular Swiss army knife? Trends Cell Biol. 12 2002 273 280
6. A.P. Lillis, I. Mikhailenko, and D.K. Strickland Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability J. Thromb. Haemost. 3 2005 1884 1893
7. B. Degryse, J.G. Neels, R.P. Czekay, K. Aertgeerts, Y. Kamikubo, and D.J. Loskutoff The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1 J. Biol. Chem. 279 2004 22595 22604
8. J. Stebbing, B. Gazzard, L. Kim, S. Portsmouth, A. Wildfire, I. Teo, M. Nelson, M. Bower, F. Gotch, S. Shaunak, P. Srivastava, and S. Patterson The heat-shock protein receptor CD91 is up-regulated in monocytes of HIV-1-infected "true" long-term nonprogressors Blood 101 2003 4000 4004
9. L. Shapiro, G.B. Pott, and A.H. Ralston Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1 FASEB J. 15 2001 115 122
10. L.F. Congote, and N. Temmel The C-terminal 26-residue peptide of serpin A1 stimulates proliferation of breast and liver cancer cells: role of protein kinase C and CD47 FEBS Lett. 576 2004 343 347
11. M.C. Gerbod-Giannone, A. Del Castillo-Olivares, S. Janciauskiene, G. Gil, and P.B. Hylemon Suppression of cholesterol 7alpha-hydroxylase transcription and bile acid synthesis by an alpha1-antitrypsin peptide via interaction with alpha1-fetoprotein transcription factor J. Biol. Chem. 277 2002 42973 42980
12. B.K. Felber, and G.N. Pavlakis A quantitative bioassay for HIV-1 based on trans-activation Science 239 1988 184 187
13. S. Schwartz, B.K. Felber, E.M. Fenyo, and G.N. Pavlakis Rapidly and slowly replicating human immunodeficiency virus type 1 isolates can be distinguished according to target-cell tropism in T-cell and monocyte cell lines Proc. Natl. Acad. Sci. USA 86 1989 7200 7203
14. A.D. Frankel, and C.O. Pabo Cellular uptake of the tat protein from human immunodeficiency virus Cell 55 1988 1189 1193
15. J. He, S. Choe, R. Walker, P. Di Marzio, D.O. Morgan, and N.R. Landau Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity J. Virol. 69 1995 6705 6711
16. R.I. Connor, B.K. Chen, and S. Choe N.RVpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes Virology 206 1995 935 944
17. L.J. Chang, V. Urlacher, T. Iwakuma, Y. Cui, and J. Zucali Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system Gene Ther. 6 1999 715 728
18. Y.L. Chiu, B. Soros, J.F. Kreisberg, K. Stopak, W. Yonemoto, and W.C. Greene Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells Nature 435 2005 108 114
19. U. O'Doherty, W.J. Swiggard, and M.H. Malim Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding J. Virol. 74 2000 10074 10080
20. G.A. Silverman, P.I. Bird, R.W. Carrell, F.C. Church, P.B. Coughlin, P.G. Gettins, J.A. Irving, D.A. Lomas, C.J. Luke, R.W. Moyer, P.A. Pemberton, E. Remold-O'Donnell, G.S. Salvesen, J. Travis, and J.C. Whisstock The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature J. Biol. Chem. 276 2001 33293 33296
21. C.E. Hirst, M.S. Buzza, C.H. Bird, H.S. Warren, P.U. Cameron, M. Zhang, P.G. Ashton-Rickardt, and P.I. Bird The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency J. Immunol. 170 2003 805 815
22. A.T. Rowshani, M.C. Strik, R. Molenaar, S.L. Yong, A.M. Wolbink, F.J. Bemelman, C.E. Hack, and I.J. Ten Berge The Granzyme B inhibitor SERPINB9 (Protease Inhibitor 9) circulates in blood and increases on primary cytomegalovirus infection after renal transplantation J. Infect. Dis. 192 2005 1908 1911
23. R. Geiben-Lynn, N. Brown, B.D. Walker, and A.D. Luster Purification of a modified form of bovine antithrombin III as an HIV-1 CD8+ T-cell antiviral factor J. Biol. Chem. 277 2002 42352 42357
24. M.R. DiFalco, and L.F. Congote Preparation of a recombinant chimera of insulin-like growth factor II and interleukin 3 with high proliferative potency for hematopoietic cells Biochem. J. 326 1997 407 413
25. M.J. Galloway, M.J. Mackie, and B.A. McVerry Elastase-alpha 1 antitrypsin complexes in acute leukaemia Thromb. Res. 38 1985 311 320
26. J.A. Levy The search for the CD8+ cell anti-HIV factor (CAF) Trends Immunol. 24 2003 628 632
27. T.L. Chang, F. Francois, A. Mosoian, and M.E. Klotman CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition J. Virol. 77 2003 6777 6784
28. T. Nassar, S. Akkawi, R. Bar-Shavit, A. Haj-Yehia, K. Bdeir, A.B. Al-Mehdi, M. Tarshis, and A.A. Higazi Human alpha-defensin regulates smooth muscle cell contraction: a role for low-density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor Blood 100 2002 4026 4032
29. C. Bovolenta, A.L. Lorini, B. Mantelli, L. Camorali, F. Novelli, P. Biswas, and G. Poli A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1 J. Immunol. 162 1999 323 330
30. J.P. Richard, K. Melikov, E. Vives, C. Ramos, B. Verbeure, M.J. Gait, L.V. Chernomordik, and B. Lebleu Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake J. Biol. Chem. 278 2003 585 590
31. Y. Liu, M. Jones, C.M. Hingtgen, G. Bu, N. Laribee, R.E. Tanzi, R.D. Moir, A. Nath, and J.J. He Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands Nature Med. 6 2002 1380 1387